Our data were consistent with previous studies showing that the NF-κB pathway was activated by Aβ1-42 stimulation and that treatment with NTN-1 significantly inhibited Aβ1-42-induced activation of the NF-κB pathway in the brains of AD rats. Here, NFKB1 is linked to Alzheimer disease.